Deferred Tax Assets, Valuation Allowance of Iridium Communications Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Iridium Communications Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Iridium Communications Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $32,941,000, a 0.18% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Iridium Communications Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $32,941,000 +$59,000 +0.18% 31 Dec 2025 10-K 12 Feb 2026 2025 FY
Q4 2024 $32,882,000 -$538,000 -1.6% 31 Dec 2024 10-K 12 Feb 2026 2025 FY
Q4 2023 $33,420,000 -$1,223,000 -3.5% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q4 2022 $34,643,000 +$121,000 +0.35% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q4 2021 $34,522,000 +$2,304,000 +7.2% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q4 2020 $32,218,000 +$2,664,000 +9% 31 Dec 2020 10-K 17 Feb 2022 2021 FY
Q4 2019 $29,554,000 +$15,380,000 +109% 31 Dec 2019 10-K/A 31 Mar 2021 2020 FY
Q4 2018 $14,174,000 +$10,359,000 +272% 31 Dec 2018 10-K 25 Feb 2020 2019 FY
Q4 2017 $3,815,000 +$990,000 +35% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 $2,825,000 -$1,704,000 -38% 31 Dec 2016 10-K 22 Feb 2018 2017 FY
Q4 2015 $4,529,000 -$2,277,000 -33% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q4 2014 $6,806,000 +$239,000 +3.6% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q4 2013 $6,567,000 +$4,367,000 +198% 31 Dec 2013 10-K 26 Feb 2015 2014 FY
Q4 2012 $2,200,000 +$1,759,000 +399% 31 Dec 2012 10-K 04 Mar 2014 2013 FY
Q4 2011 $441,000 31 Dec 2011 10-K 05 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.